This is a useful inventory of agents that assist in dealing with neuropathy.
It is my opinion based of the pattern of evidence that we are dealing with toxin capture from dying cells impacting nerve ends where the toxins have actually accumulated. Diabetic neuropathy is a clear cause effect example in which the cause is impacting the whole body, but with the toxins accumulating in the limbs in particular. I do suspect that toxins will also activate incipiant conditions such as arcthritis.
what none of these protocols address is toxin removal which really needs to be better understood if my conjecture holds up.
So i throw this out as well. You get the point. We may well be dealing with an un identified metabolic toxin as well or a preferred pathway that needs to be minimized. My point is that chasing inflamation is a proven dead end and only postpones accumulating toxin damage.
Limit Alcohol. More than 90% of alcohol is metabolized in your liver ( 4 ). ...
Focus on Sleep. ...
Drink More Water. ...
Reduce Your Intake of Sugar and Processed Foods. ...
Eat Antioxidant-Rich Foods. ...
Eat Foods High in Prebiotics. ...
Decrease Your Salt Intake. ...
Get Active.
Medicinal herbs in the treatment of neuropathic pain: a review
Introduction
Pain, an unpleasant sensation and emotional experience that in our daily life, is an alert of tissue injury to prevent further or impending tissue damage (1). Acute pain is a useful biologic purpose and self-limiting in nature that arises in response to a specific injury. Chronic pain, in contrast, may be considered as a disease state. It may outlast the usual duration of recovery, if accompanied with a disease or injury (1, 2). The definition of chronic neuropathic pain is “pain that comes from direct consequence of a lesion or disease which affect the somatosensory system” (3). It may be classified as central or peripheral, depending on the site of the lesion. The most causes of chronic neuropathic pain are metabolic disease, viral, trauma, severe ischemic insults, and autoimmune diseases (4-6).
Neuropathic pain usually does not have effective treatment, because of heterogeneous etiology and complex underlying pathophysiology, moreover, the unwanted side effect profiles limit the use of available drugs (7-9).
Neuropathic pain and underlying mechanisms
Neuropathic pain may be spontaneous or evoked in response to physical stimuli, that may manifest as increased sensitivity to pain (hyperalgesia) or as a pain evoked by a nonpainful stimuli (allodynia) (5, 10). Once injury occurs, inflammation and reparatory processes ensue, leads to a hyperexcitable state known as peripheral sensitization. Many types of peripheral mechanisms have been described, in most patients, this state resolves as healing occurs and inflammation subsides. But, stimulation from ongoing injury or disease lead to persist nociception, then the changes in primary afferent neurons may continue (11). Central changes can result from peripheral nerve lesions, which have been investigated in animals mainly at the spinal cord or sometimes at supraspinal levels (12, 13).
Several types of alterations can induce pathologic activation of central nociceptive neurons: such as neuroplasticity, microglial activation and hyper-excitability (central sensitization) of nociceptive neurons. Central sensitization possibly depends critically on intracellular changing that induced by the activation of N-methyl-D-aspartate (NMDA) and glutamate metabotropic receptors (12, 13). The stimulation of non-neuronal cells, microglia in central and macrophages in periphery, leads to production of a variety inflammatory cytokines and chemokines which play critical roles in neuropathic pain condition (14, 15).
Neuropathic pain and herbal medicinal products
The usage of natural products, principally herbal medicines is one of the ancient therapies used by humanity (16). During the recent years, people are eager to use herbal medicines due to their lower complications and fewer side effects than synthetic drugs (17). Regarding to the increasing demand for medicinal plants and related compounds the phytopharmaceutical studies and the use of these remedies for the management of painful neuropathy have been growing throughout the world (18).
Animal models and/or pharmacological mechanisms of neuropathic pain
Animal models of neuropathic pain have been essential in the exploration of molecular mechanisms of pain also for the analysis of novel analgesics in the treatment of chronic pain (19). The animal models for studying neuropathic pain and a brief description of each model are as follows:
The streptozotocin (STZ)-induced diabetes
The STZ-induced diabetic neuropathic pain model mimics the diabetic neuropathy. This neuropathy is one of the most frequent peripheral neuropathies associated with hyperalgesia, cold or hot allodynia and hyperesthesia, the high blood glucose level induced oxidative and nitrosative stress which have been proposed to be an essential mechanism of neuronal injury related to diabetic neuropathy (20-22). Reactive oxygen species (ROS) enhanced nociceptors sensitization so that they not only respond more vigorously towards noxious stimuli, but also start to respond towards normally subthreshold stimuli. This peripheral sensitization not only induces pain directly but furthermore induces central sensitization in the spinal cord, which also indirectly contributes to pain (7, 23). In high concentrations superoxide combine with nitric oxide to form peroxynitrite, which is implicated in diabetes accompanied by motor and sensory nerve conduction deficits, in addition to peripheral nerve energy deficiency (7, 24).
High-fat diet
High-fat diet is an important risk factor for nerve conduction velocity deficit and small sensory fiber neuropathy with alimentary obesity, hyperinsulinemia, and impaired glucose tolerance develops neuronal damage resulting from oxidative stress of lipid metabolism and indicate increased sorbitol pathway activity, oxidative-nitrosative stress, and pro-inflammatory changes in peripheral nervous system (PNS) (25, 26). This model has been used in studies on pathophysiology of impaired glucose tolerance (IGT) and type 2 diabetes and for development of new treatments (27).
Neuropathy produced by sciatic nerve injury
The experimental model of neuropathy produced by sciatic nerve injury in animals mimic symptoms observed in human beings with nerve injury, and this model is widely used in behavioral examination. In this model, prolonged changes in neurotransmitter and receptor expression, lead to produce central sensitization in response towards the release of numerous inflammatory and pain mediators observed, which in turn enhances the sensitivity of peripheral sensory afferents at the site of injury and also in the CNS (7).
Chemotherapy-induced peripheral neuropathy
Peripheral neuropathy is a common side effect of many classes of anti-cancer drugs, the major classes of chemotherapy drugs that induce peripheral neuropathy (CIPN) including the antitubulins (paclitaxel, docetaxel, ixabepilone, and vincristine), platinum analogs (oxaliplatin, carboplatin, and cisplatin), and the proteasome inhibitors such as bortezomib and thalidomide. These drugs exert direct and indirect effects on sensory nerves to diminish the amplitude of action potential, slow conduction velocity and induce pain in patients, mainly those who experience nociceptive sensory loss through their cancer treatment (28, 29).
Research methodology
The current search was done in databases of Google Scholar, Medline and Scopus, using the following keywords: neuropathic pain, medicinal plants, phytotherapy and natural products. The search included literatures published as late as 31 April 2017.
In the present review, plants and some constituents of herbal medicine which have the potential to cure neuropathic pain have been discussed alphabetically.
Table 1
Herbal medicines and their constituents tested for neuropathic pain in human studies
NMDA: N-methyl-D-aspartate; CNS: central nervous system; PNS: peripheral nervous system; STZ: streptozotocin; ROS: reactive oxygen species; CIPN: chemotherapy drugs that induce peripheral neuropathy; HAE-AC: hydroalcoholic extract of A. calamus; MPO: myeloperoxidase; TST: tibial and sural nerve transection; CCI: chronic constriction injury; TBARS: thiobarbituric acid reactive substances; GSH: glutathione; PDPN: painful diabetic polyneuropathy; 6-OHDA: 6-Hydroxydopamine; PCPA: p-chlorophenylalanine; COX-2: cyclooxygenase 2; MDA: malondialdehyde; SNL: spinal nerve ligation; NOS: nitric oxide synthase; PSNL: partial sciatic nerve ligation; EEPp: ethanolic extract from P. pubescens fruits; THC/CBD, A9-Tetrahydrocannabinol/Cannabidiol; DRG: dorsal root ganglion; 3α-HSOR: 3α-Hydroxysteroid oxidoreductase; SOD: superoxide dismutase
Table 2
Mechanisms of actions of herbal medicines against neuropathic pain in animal models
Acorus calamus
A. calamus, belongs to Araceae family, it has been used for the management of several inflammatory disorders in Indian traditional medicine (30). The hydroalcoholic extract of A. calamus (HAE-AC) has been shown to significantly attenuate thermal hyperalgesia, thermal allodynia and mechanical hyperalgesia on neuropathic pain induced by tibial and sural nerve transection (TST) in rats. Moreover, a significant decrement in the superoxide anion, total calcium levels and myeloperoxidase (MPO) activity were also observed (31). Furthermore, HAE-AC decreased superoxide anion, total calcium levels and MPO activity in sciatic nerve chronic constriction injury (CCI). It also attenuated CCI induced development of painful behavioral changes including: thermal, radiant, mechanical hyperalgesia and thermal, chemical, tactile allodynia in rats (32). In other study, HAE-AC attenuated the development of painful behavioral (thermal and mechanical hyperalgesia and mechanical allodynia), biochemical (rises in the levels of superoxide anion, total calcium and myeloperoxidase activity) and histological changes in vincristine-induced neuropathy in rats (33). In a further study saponin rich extract of A. calamus (20 and 40 mg/kg) significantly improved CCI-induced nociceptive pain threshold, sciatic functional and electrophysiological changes in rats (34). These effects may have been exerted probably by multiple mechanisms containing antioxidative, anti-inflammatory, calcium inhibitory activity and neuroprotective actions (31-33).
Alstonia scholaris
A. scholaris belongs to Apocyanaceae family, it has been used for treating diarrhea, dysentery, malaria, fever and cardiac diseases as well as rheumatic pains in traditional medicine (35).
Singh et al. in 2017, showed that methanol extract of A. scholaris significantly attenuated heat hyperalgesia, mechanical hyperalgesia and cold allodynia as well as protection against oxidative stress and inflammatory activity in CCI rats (36). They have suggested that the therapeutic effect of this extract may be due to the presence of kaempferol and attributed to inhibit the inflammatory cytokines and ROS production (36).
Artemisia dracunculus
Artemisia species are beneficial herbal remedies with antioxidant and anti-inflammatory effects (25, 37). A. dracunculus, belongs to Asteraceae family, display anti-inflammatory and antinociceptive effects (25, 35). PMI-5011, is an ethanolic extract of A. dracunculus. PMI-5011 normalized glycemia, improved nerve conduction slowing and sensory neuropathy, and diminished 12/15-lipoxygenase upregulation and nitrated protein expression in peripheral nervous system in rats with high-fat diet-induced neuropathy of prediabetes and obesity, potentially, by multiple mechanisms that are including the inhibition of oxidative nitrosative stress and lipoxygenase activation (25). Another study demonstrated that A. dracunculus leaf aqueous extract diminished the acute and chronic pain on fructose fed male rats (38).
Butea monosperma
B. monosperma is distributed in deciduous forest and in open areas. It has been used in traditional medicine for various therapeutic effects such as diuretic, anti-diabetic, anthelmintic, antimicrobial, arthritis, wound healing in addition to treating burning sensation of the body (39, 40). Pretreatment with B. monosperma significantly increased the behavioral (i.e. hyperalgesia and allodynic pain sensation) changes and decreased thiobarbituric acid reactive substances (TBARS), total calcium levels besides increased the glutathione (GSH) levels in the sciatic nerve tissue when compared with the normal control group on vincristine-induced neuropathic pain model in rats, that may be due to its potential of neuroprotective, antioxidant and calcium channel inactivation (39). Another study investigated the ameliorative effect of ethanolic extract from leaves of B. monosperma in CCI model. Pretreatment of B. monosperma attenuated CCI induced development of histopathological, biochemical and behavioral alterations dose dependently, which is comparable to that of pregabalin pretreated group. This may be due to its potential anti-oxidative, neuroprotective and calcium channel modulatory effects of B. monosperma (40).
Citrullus colocynthis
C. colocynthis (cucurbitaceae), endemic in Southern Tunisia, in folk medicinal used as an analgesic and anti-inflammatory agents (41). Aqueous extracts of the plant in acetic acid writhing test in mice and the carrageenan-induced paw edema assay in rats had analgesic and anti-inflammatory effects (41). More recently, in a two-arm double-blind randomized placebo-controlled clinical trial using a parallel design, sixty painful diabetic polyneuropathy (PDPN) patients were randomly allocated to treat either with a topical formulation of C. colocynthis or placebo, after 3 months the results showed that administration of a topical formulation of C. colocynthis fruit extract diminished pain in patients with PDPN (42).
Curcuma longa
C. longa, a perennial herb of the ginger family, is cultivated widely in south and southeast tropical Asia. It has been used medically for thousands of years (43). As a main constituent of C. longa, curcumin has a variety of pharmacological properties such as antioxidant and anti-inflammatory activities (43, 44). Curcumin improved mechanical allodynia and thermal hyperalgesia in CCI mice along with increasing spinal monoamine (or metabolite) contents. 6-Hydroxydopamine (6-OHDA) totally abolished the effects of curcumin on mechanical allodynia and p-chlorophenylalanine (PCPA) completely blocked the antinociceptive influence of curcumin on thermal hyperalgesia. Chronic co-treatment with the β2-adrenoceptor antagonist ICI 118,551, or by acute co-treatment with the delta-opioid receptor antagonist naltrindole blocked the anti-allodynic action of curcumin on mechanical stimuli. However, co-treatment with the irreversible mu-opioid receptor antangonist β-funaltrexamine acutely or with the 5-HT1A receptor antagonist WAY-100635 chronically completely abrogated the anti-hyperalgesic effect of curcumin on thermal stimuli. According to these results, the descending monoamine system (coupled with spinal β2-adrenoceptor and 5-HT1A receptor) for antinociceptive properties of curcumin in neuropathic pain is crucial. Delta- and mu-opioid receptors are likely rendered as downstream targets (44). In another study, curcumin reduced mechanical and cold allodynia and attenuated the serum concentration of cyclooxygenase 2 (COX-2) in CCI model of neuropathic pain in rats, that may be mediated, at least partially, by reducing the inflammatory effects of COX-2 enzyme activity (45).
Crocus sativus'
C. sativus commonly known as saffron, belongs to the Iridaceae family and extensively cultivated in Iran and other countries such as India and Greece (46, 47). It is used traditionally as food and remedy for several disorders including bronchospasm, insomnia, asthma, menstruation problems, pain relief and cardiovascular disorders (48). Chemical studies have shown that most important bioactive constituents of C. sativus are crocin, crocetin, safranal and picrocrocin (49, 50). The ethanolic and aqueous extracts of saffron as well as safranal attenuated the behavioural symptones of neuropathic pain in CCI model in rats (48). Besides, the ethanolic and aqueous extracts of C. sativus attenuated malondialdehyde (MDA) and increased GSH levels in CCI animals (51). Safranal showed an anti-nociceptive effect in chemical (formalin and acid acetic tests) methods of nociception in mice (52). Stigma extracts of C. sativus exerted anti-inflammatory effects (53). A recent study showed that saffron and crocin (30 mg/kg) reduced thermal hyperalgesia and mechanical allodynia, but crocin at lower dose (15 mg/kg) was ineffective to produce protective effects (54). Ethanolic and aqueous extracts of C. sativus as well as safranal diminished allodynia and hyperalgesia induced by (CCI) of the sciatic nerve, besides C. sativus extracts significantly decreased the lumbar spinal cord contents of MDA and proinflammatory cytokines (TNFα, IL-1β, IL-6) (55). A more recent study showed that, saffron as an adjunctive therapy in combination with amitriptyline lead to improvement of the therapeutic outcome in the management of neuropathic pain (56).
Elaeagnus angustifolia
E. angustifolia (Elaeagnaceae) is cultivated from the northern areas of Asia to the Himalayas and Europe because of its ability to grow in a wide range of environmental conditions (57, 58). In Iranian traditional medicines, E. angustifolia fruit has been used as an analgesic agent for decreasing of pain in rheumatoid arthritis (59). E. angustifolia showed muscle relaxant (60) and anti-inflammatory (61) activity. Administration of different doses of this fruit showed significant analgesic effect on nerve ligated mice in hot plate test (57). Flavonoids have been considered the most essential components in E. angustifolia that have been related to antinociceptive and anti-inflammatory activities (62). Recently in a randomized controlled trial study E. angustifolia extract reduced the symptoms of osteoarthritis with an efficacy comparable to that of ibuprofen. It was also safe and well tolerated during the course of trial and no adverse effect was seen (63).
Ginkgo biloba
G. biloba is the popular herb that has shown some neuroprotective effects such as protective activity against transient and permanent focal cerebral ischemia (64) and dementia (65). The most unique constituents of the G. biloba extracts are the terpene trilactones, that are, ginkgolides and bilobalide. In a study, conducted by Kim, et al., administration of G. biloba extract, EGb 761, lead to reduction of the paw withdrawal thresholds to mechanical stimuli and withdrawal frequencies to cold stimuli in the rat model of neuropathic pain induced by spinal nerve ligation (SNL). The beneficial effect of G. biloba extract on neuropathic pain was likely due to a combination of an anti-inflammatory, antioxidant effect, a platelet activating factor antagonist and a protective effect against NMDA induced neurotoxicity (66). Administration of EGb 761, a standardized extract of G. biloba, after the third week of STZ administration for 14days reversed diabetes induced thermal hyperalgesia and mechanical allodynia on STZ-induced neuropathic pain in rats by inhibiting oxidative and nitrosative stress (67).
Mitragyna speciosa
M. speciosa (Korth.) belongs to Rubiaceae family, is endemic to tropical Southeast Asia (68). The leaves of M. speciosa have been used for medicinal purposes such as relieve muscle pain and fever (69), and has long been used in Thailand for its opioid-like effects (70). 7-Hydroxymitragynine is an indole alkaloid and was found to possess the most potent opioid agonistic effects among the components isolated from the traditional herbal medicine M. speciose (70). Matsumoto et al. developed dual-acting µ- and ∆-opioid agonists MGM-15 and MGM-16 from 7-hydroxymitragynine for the treatment of acute and chronic pain. MGM-16 exhibited a higher potency than that of 7-hydroxymitragynine and MGM-15 in in vitro and in vivo assays. Also MGM-16 exhibited a high affinity for µ- and ∆-opioid receptors both in vitro and in vivo tests. Systemic administration of MGM-16 caused antinociceptive effects in a mouse acute pain model and antiallodynic effects in a neuropathic pain model in mice (70). A recent study demonstrated that M. speciosa produced antinociceptive effects similar to the reference opioid agonists (69).
Momordica charantia
M. charantia (Cucurbitaceae) grows in Asia, Africa, and Latin America and is used traditionally as food and remedy for several disorders such as asthma and anaemia (71). Administration of M. charantia significantly attenuated TST induced behavioral alterations including cold, mechanical, and heat hyperalgesia, dynamic mechanical allodynia, and cold allodynia in rats. Furthermore, treatment of M. charantia also prevents TST-induced rise in nerve tissue TNF-alpha and TBARS contents. It is speculated that PPAR-gamma agonistic effect, anti-inflammatory, and antioxidative potential is critical for antinociceptive effect of M. charantia in neuropathic pain (72).
Nigella sativa
N. sativa is an annual flowering plant belonging to the Ranunculaceae family (73, 74). It consists of more than 30% fixed oil and 0.4%-0.45% volatile oil. The volatile oil have 18.4%–24% thymoquinone (TQ) (75, 76). N. sativa and TQ caused a significant reduction in elevated serum glucose and increased the lowered serum insulin concentration. They also increased the level of insulin immunoreactive β-cells. The histologic evaluation of the tissues in diabetic animals treated with TQ and especially N. sativa exhibited fewer morphologic alterations. The results are attributed to its direct and indirect antioxidant actions of TQ and especially N. sativa (76). Another study showed that administration of TQ significantly improved behavioral signs and apoptotic factors also oxidative effects of neuropathic pain in CCI rats (77). In a study conducted by Tewari et al., N. sativa showed significant analgesic effects on cisplatin induced neuropathic pain in rats (78).
Ocimum sanctum
O. sanctum is an indigenous plant commonly found in India and is recommended in the Ayurveda to treat various diseases such as arthritis and painful eye diseases (79). Treatment with O. sanctum attenuated sciatic nerve transection-induced axonal degeneration, decrement of nociceptive threshold and motor in-coordination. Furthermore, it also attenuated axotomy-induced increase in TBARS, total calcium and diminution in GSH levels (80). In another study treatment with O. sanctum and its saponin rich fraction significantly attenuated vincristine-induced increase in the withdrawal duration of the hind paw in response to non-noxious cold stimuli and noxious mechanical stimuli and significantly decreased the vincristine-induced increase in oxidative stress markers and total calcium levels in vincristine-induced neuropathic pain in rats, which may be attributed to diminution in oxidative stress and calcium levels (79). A recent study showed that O. sanctum has potential effects in attenuating painful neuropathic state in CCI-induced peripheral neuropathy, and saponins may be the key chemical class responsible for its useful effect in neuropathic pain. Besides, the authors suggested that the pain relieving effects of O. sanctum and its saponin rich fraction may be via to attenuation of nerve injury inciting agent-induced increased contents of calcium and free radicals (81).
Phyllanthus amarus
The plants belonging to the genus Phyllanthus (Euphorbiaceae) have more than 600 species, which are extensively distributed in most tropical and subtropical countries (82). Several species from the genus Phyllanthus are extensively used in traditional medicine, in several countries, to treat of numerous diseases including flu, dropsy, diabetes, jaundice and bladder calculus (82). The hexanic extract of P. amarus inhibited the mechanical allodynia in mice after the partial ligation of the sciatic nerve, with a quite similar efficacy to that obtained with gabapentin. Administration of hexanic extract inhibited the increase of MPO activity, either following intraplantar injection of complete Freund’s adjuvant (CFA) or after partial sciatic nerve ligation (PSNL) partly via the anti-inflammatory actions (82). It has been suggested that the antihyperalgesic and anti-inflammatory properties of P.amarus in a model of chronic musculoskeletal inflammatory pain are mediated through spinal or supraspinal neuronal mechanisms, principally by inhibition of PGE2 (73).
Pterodon pubescens Benth.
P. pubescens Benth. (Leguminosae) is a tree native to central Brazil that has been used in folk medicine for its anti-inflammatory, anti-rheumatic and analgesic activities (83).
The hexane fraction of the ethanolic extract of the fruits of P. pubescens Benth induced anti-inflammatory effects in two animal models including: carrageenan-induced inflammatory reaction in the pleural cavity and complete Freund’s adjuvant-induced arthritis (84). Administration of ethanolic extract from P. pubescens fruits (EEPp) causes significant inhibition of mechanical and thermal (heat and cold) hyperalgesia induced by PSNL in mice (83). Also, oral administration of EEPp diminished nociceptive behavior induced by intrathecal injection of TRPV1 and TRPA1channels activators (capsaicin and cinnamaldehyde, respectively). The treatment with EEPp inhibited the nociceptive behavior responses induced by the following intrathecal injections with glutamate, kainate, NMDA and trans-ACPD. In addition, EEPp also inhibited the nociceptive behavior responses induced by intrathecal injection of proinflammatory cytokines (TNF-α andIL-1β). These effects may be mediated at least in part, by the inhibition of proinflammatory cytokines, glutamatergic receptors as well as TRPV1 and TRPA1 channels (83).
Rosmarinus officinalis
R. officinalis commonly known as rosemary, belongs to Labiatae family. This plant has been used in traditional medicine for several disorders such as dysmenorrhea and rheumatic pain (85). Rosemary is rich in caffeic acid, rosmarinic acid, ursolic acid, carnosic acid and carnosol compounds (86). Administration of rosmarinic acid and ethanolic extract of R. officinalis decreased contents of spinal inflammatory markers comprising matrix metallopeptidase 2 (MMP2), COX2, IL-1b and PGE- 2 in CCI rats (87). The ethanolic extract of aerial parts of R. officinalis significantly diminished the amounts of glial activity, inflammation, and apoptosis markers in CCI rats (88).
Rubia cordifolia
R. cordifolia (Rubiaceae) is an ayurvedic herb. Common names of this plant are Indian madder, majit and manjishtha. It is distributed all over the lower hills of Himalayas in the North and Western Ghats in the Peninsula, Ceylon, South India, Japan, Indonesia, Java and in tropical Africa moist temperate and tropical forests (89). Generally root, leaves, fruits, stem etc. of the plant R. cordifolia are used for their therapeutic properties such as analgesic and anti-inflammatory activities (89). Patel et al. investigated the analgesic and anti-inflammatory activities of this plant. They showed that methanolic extract of the root of R. cordifolia significantly reduced in the paw edema produced by the carrageenan and increased the reaction time in tail flick test (89). In a further study, administration of alcoholic extract of roots and rhizomes of R. cordifolia significantly decreased withdrawal latency in cold allodynia method and withdrawal latency in the hot plate method in paclitaxel-induced neuropathic pain in rats. The results may be because of the involvement of GABA or antioxidant mechanism (90).
Salvia officinalis
S. officinalis (sage, also called garden sage, or common sage) (family: Lamiaceae) can be found worldwide. This plant is suitable to relive of unilateral headaches and headaches with neurological origin (91). The different extracts of S. officinalis in enzyme dependent and enzyme-independent lipid peroxidation systems showed an antioxidant activity (92) and anti-inflammatory properties (28). Qnais and colleagues demonstrated that the aqueous and butanol extracts of S. officinalis increased the latency on hot-plate assay and showed antinociceptive response in both phases of formalin and the carrageenan-induced paw oedema in rats (93). The hydroalcoholic extract of S. officinalis leaves presents significant anti-inflammatory as well as antinociceptive effects on chemical behavioral models of nociception that involves an opioid mechanism. Furthermore, carnosol and ursolic acid/oleanolic acid contained in this plant appears to contribute for the antinociceptive effect of the extract, probably via a modulatory effect on TRPA1-receptors (94). In another in vivo study the hydroalcoholic extract of S. officinalis elicited anti-inflammatory effects and decreased pain response on vincristine-induced peripheral neuropathic pain in mice (95). Salvigenin (5-Hydroxy-6,7,4’-trimethoxy flavones) is one of the active flavonoids found in this plant. Salvigenin in a dose dependent manner demonstrated a significant analgesic effect like morphine (91).
Constituents of herbal medicine with protective effect against neuropathy
A9-Tetrahydrocannabinol/Cannabidiol (THC/CBD)
Cannabis sativa has a long history of use as a medicinal agent (96). THC/CBD is derived from strains of C. sativa plant developed to produce high and reproducible yields of THC and CBD, with trace quantities of other cannabinoids and terpenes in a solution having ethanol, propylene glycol, and peppermint oil flavoring. THC and CBD contain ≥ 90% of the total cannabinoid content of the extracts (97). THC/CBD display many pharmacologic effects such as anti-inflammatory, appetite stimulant and antiemetic effects (96). THC/CBD has been approved in Canada as adjunctive treatment for the symptomatic improve of neuropathic pain in multiple sclerosis (MS) in adults (97). The standardized extract of C. sativa evoked a total relief of thermal hyperalgesia, in CCI model in rat, that was mediated by vanilloid receptors TRPV1 (96). A phase II randomized clinical trial study showed that administration of active cannabis ranging in potency between 1 and 8% D-9-tetrahydrocannabinol significantly reduced neuropathic pain intensity in HIV-associated distal sensory predominant polyneuropathy (DSPN). These results showed that cannabinoid therapy may be an effective choice for pain relief in patients with medically intractable pain due to HIV-associated DSPN with mild and self-limited side effects (98). Moreover, in randomized controlled trials THC/CBD was effective in patients with central neuropathic pain and MS who completed -2 years of treatment with no evidence of tolerance (97). Also Johnson et al. in a double-blind, randomized, placebo-controlled, parallel-group trial study showed that THC/CBD is a useful adjunctive treatment for relief of pain in patients with intractable cancer-related pain who experience inadequate analgesia despite chronic opioid therapy (99). Same authors in an open-label extension study showed that long-term use of THC/CBD spray relieved cancer-related pain and generally well tolerated in advanced cancer patients. Moreover, patients who kept using the study medication did not seek to increase their dose of THC/CBD spray over time (100). Recently, in a double-blind, randomized, placebo-controlled, parallel group study administration of THC/CBD oromucosal spray in patients with peripheral neuropathic pain clinically improved their pain, sleep quality and global impression of change in the severity of their condition (101). More recently in a multicenter, open-label, follow-on study THC/CBD spray was beneficial for the majority of patients that have peripheral neuropathic pain associated with diabetes or allodynia. THC/CBD spray was well tolerated during the study period and also patients did not seek to increase their dose over time, with no new safety concerns arising from long-term use (102).
Lappaconitine
Since ancient times, preparations of various species of Aconitum have been widely used. Aconitine and related alkaloids, derived from Aconitum species, had various pharmacological effect such as analgesic and anti-inflammatory (103, 104). Treatment with Aconitum (including both Radix aconite preparata and Radix aconite kusnezoffii), mixture with Huangqi Guizhi Wuwu Tang (i.e., astragalus, cassia twig, white peony root, and spatholobi) in the four diabetic peripheral neuropathic pain subjects, lead to remarkably reduction of pain and the EMG profile was also improved. Adverse reactions were not observed during the therapy (105). Lappaconitine (LA) is aconitum alkaloid that extracted from the root of the plant Aconitum species. LA has been used as analgesic for centuries in the world, especially in China and Japan (106). Administration of LA showed inhibitory effect on the nociceptive behaviors induced by CCI, diminished the expression of the P2X3 receptors in the dorsal root ganglion (DRG) neurons and inhibited the fast IATP and Ia,β-meATP in the DRG neurons of the CCI rats via regulating the purinergic signaling system at DRG level (107).
DA-9801
DA-9801 is a botanical drug, extracted from Dioscorea species including: D. rhizoma and D. nipponica Makino (108). Many species of Dioscorea have traditionally been used clinically in Asia to treat numerous syndromes associated with metabolic disorders. Besides, the extracts of the Dioscorea species had antidiabetic and antiobesity effects (108-110).
Administration of DA-9801 improved damage produced by diabetic neuropathy by increasing the levels of NGF in plasma and the sciatic nerve and showed improvement on nerve conduction velocity and recovery from neuronal degeneration in STZ rat/mouse diabetic models and in db/db mouse model (111). Another study demonstrated that oral treatment with DA-9801 decreased the blood glucose contents and increased the withdrawal latencies in hot plate procedures. Furthermore, it prevented nerve injury based on increased nerve conduction velocity and ultrastructural changes (108).
Goshajinkigan
In Japan, TJ-107 (Goshajinkigan) is a complex drug containing 10 medicinal herbs that has been commonly prescribed to improve symptoms of diabetic peripheral neuropathy for example numbness, cold sensation, and paresthesias/dysesthesia. In a phase 2 randomized, double-blind, placebo-controlled study, oral administration of TJ-107 had acceptable margins of safety and tolerability and a promising influence in delaying the onset of grade 2 or greater oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients treated with oxaliplatin (112).
In a randomized open-labeled clinical trial study, long-term administration of Goshajinkigan showed beneficial effects on macrovascular diseases, retinopathy or nephropathy in type 2 diabetic mellitus patients (113).
Incarvillateine
Incarvillea sinensis is a big noniaceae plant distributed in Northern China. It has been widely used as a traditional herbal medicine for treatment of rheumatism, bruises and wounds. It also is effective in decreasing pain and inflammation in traditional Chinese medicine (114). Incarvillateine is considered the major active constituent of this plant. Administration of incarvillateine attenuated formalin-induced pain in mice with a higher potency than morphine (115). Furthermore, the antinociceptive action of incarvillateine attenuated by non-selective adenosine receptor antagonist, non-selective opioid receptor antagonist, and μ and κ opioid receptor antagonists (116). Administration of incarvillateine in a dose-dependent manner decreased acetic acid-induced writhing and also inhibited both thermal hyperalgesia and paw edema, and increased interleukin-1β levels in Complete Freund’s Adjuvant model. Furthermore, incarvillateine reduced mechanical allodynia induced by SNI or paclitaxel. Additionally, incarvillateine-induced antinociception was reduced by theophylline, 1,3-dipropyl-8-cyclopentylxanthine, and 3,7-dimethyl-1-propargylxanthine, but not naloxone. It seems the mechanism of antinociceptive effects are mediated by adenosine receptors, but not the opioid receptor system (114).
Koumine
Gelsemium is a genus of the family Loganiaceae, G. elegans Benth. has long been used in Chinese traditional medicine to relieve pain, inflammation, and cancer (117). Koumine is an alkaloid monomer found abundantly in Gelsemium plants (118). Koumine attenuated tactile allodynia, improve sensory nerve conduction, and mitigate the pathology of sciatic nerves in STZ-induced diabetic rats (119). In another study koumine suppressed thermal hyperalgesia and mechanical allodynia more potently than gabapentin in CCI rats (118).
Upregulation of allopregnanolone induced significant analgesia, indicating that allopregnanolone in the spinal cord (SC) may be an essential key modulator of neuropathic pain. 3α-Hydroxysteroid oxidoreductase (3α-HSOR) is responsible for allopregnanolone upregulation in the SC. The activity of 3α-HSOR in the SC of koumine-treated CCI rats increased by 15.8% as compared to untreated CCI rats. Also, the intrathecal injection of medroxyprogesterone acetate, a selective 3α-HSOR inhibitor, dose-dependently reversed the analgesic effect of koumine on CCI-induced mechanical pain perception. The authors suggested that koumine altered 3α-HSOR-regulated allopregnanolone levels in the SC of rat. Elevated allopregnanolone levels may exert analgesic effects through allosteric modulation of GABAA and by suppressing the release of microglia activation-induced inflammatory cytokines (118).
Naringin
Naringin, a flavanone-7-O-glycoside derived from grape fruit and related citrus species, has metal-chelating, antioxidant and free radical scavenging effects (120). Administration of naringin increased the level of nociceptive threshold, endogenous antioxidant and membrane bound inorganic phosphate enzyme. It also diminished the oxidative–nitrosative stress level, inflammatory mediators as well as apoptosis in neural cells in STZ induced diabetic neuropathic pain. The results may be due to antioxidant and antiapoptotic activity of naringin (120).
In a recent study naringin in a dose dependent manner reduced the mechanical allodynia and thermal hyperalgesia induced by SNL, as well as markedly inhibited peripheral neuropathy-induced activation of glial cells (astrocytes and microglia) (121). Naringin significantly increased PPARγ expression and superoxide dismutase (SOD) contents, reduced MDA contents, and improved the activities of main inflammatory cytokines including TNF-α, IL-1β, and IL-6 in the STZ induced diabetic rats (122).
Quercetin
Quercetin is a phenolic compound extensively distributed in the plant kingdom. It is found in frequently consumed foods, including berries, onions, apples, tea and brassica vegetables. Quercetin has several beneficial effects on human health such as cardiovascular protection and anti-inflammatory effects (123). Administration of quercetin significantly increased in tail-flick latencies in both diabetic and nondiabetic mice. Quercetin-induced increase in nociceptive threshold was reversed by an opioid receptor antagonist (naloxone) in nondiabetic and diabetic mice. The protective effect of quercetin was probably mediated via modulation of opioidergic mechanism in STZ induced diabetic mice (123). Another study showed that quercetin can alleviate high glucose-induced damage to Schwann cells by autophagy (124). In one study, quercetin reduced renal damage including: epithelial desquamation, swelling, intracytoplasmic vacuolization, brush border loss and peritubular infiltration in STZ-induced diabetic nephropathy rats (125). A recent study showed that the effect of quercetin was significantly superior to gabapentin and morphine in terms of improving mechanical and thermal hypersensitivity in a rat model of CCI (126).
Conclusion
The urgent need to find an alternative therapy which can improve neuropathic pain effectively with few side effects led scientists to find medicines from natural sources. This review suggests that herbal medicines are alternative options to relieve and manage neuropathic pain. Results from the current study suggest that the most pathways involved in the analgesic effects of herbal remedies are antioxidant, anti-inflammatory, anti-apoptotic, neuroprotective and calcium inhibitory actions.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960749/
This article has been cited by other articles in PMC.
| Substance | Neuropathic disorders | Study type | Results | References |
|---|---|---|---|---|
| A9-Tetrahydrocannabinol/Cannabidiol (THC/CBD) | HIV-associated distal sensory predominant polyneuropathy | Phase II, double-blind, placebo-controlled, crossover trial | Reduced neuropathic pain intensity | (98) |
| THC/CBD | Central neuropathic pain in patients with multiple sclerosis | Randomized controlled trials | Improvement in neuropathic pain without evidence of tolerance | (97) |
| THC/CBD | Patients with intractable cancer-related pain | Multicenter, double-blind, randomized, placebo-controlled, parallel-group study | Reduced neuropathic pain | (99) |
| THC/CBD | Patients with terminal cancer-related pain refractory to strong opioid analgesics | An open-label extension study | Well tolerated and reduced pain | (100) |
| THC/CBD | Patients with peripheral neuropathic pain | A double-blind, randomized, placebo-controlled, parallel group study | Improvement in neuropathic pain | (101) |
| THC/CBD | Patients with peripheral neuropathic pain | A multicentre, open-label, follow-on study | Improvement in neuropathic pain | (102) |
| Aconitum | Patients with diabetic peripheral neuropathic pain | Controlled clinical trials study | Reduced diabetic peripheral neuropathic pain | (105) |
| Citrullus colocynthis | Painful diabetic polyneuropathy patients | Double-blind randomized placebo-controlled clinical trial | Reduced diabetic polyneuropathy pain | (42) |
| Goshajinkigan | Oxaliplatin-induced neuropathy patients | Phase 2, multicenter, randomized, double-blind, placebo-controlled trial | Delayed the onset of grade 2 or greater oxaliplatin-induced neuropathy | (112) |
| Substance | Animal model | Mechanisms of actions | References |
|---|---|---|---|
| Pterodon pubescens Benth | Partial sciatic nerve ligation (PSNL) in mice | Inhibition of proinflammatory cytokines, glutamatergic receptors as well as TRPV1 and TRPA1 channels | (83) |
| Shanzhiside methylester | Spinal nerve injury (SNI) in rat | Microglial β-endorphin expression via p38 MAPK signaling | (15) |
| Emblica officinalis | Streptozotocin (STZ)-induced diabetes in rat | Modulation of oxidative–nitrosative stress | (21) |
| PMI-5011 | High-fat diet-induced neuropathy in mice | Inhibition of oxidative nitrosative stress and lipoxygenase activation | (25) |
| Rubia cordifolia | Paclitaxel-induced neuropathic pain in rat | Involvement of GABA or antioxidant mechanism | (90) |
| EGb 761 | SNL in rat | Anti-inflammatory, antioxidant effect, a platelet activating factor antagonist and a protective effect against NMDA. | (66) |
| Ocimum sanctum | Vincristine-induced neuropathic pain in rat | Decrement of oxidative stress and calcium levels | (79) |
| Acorus calamus | Tibial and sural nerve transection (TST) in rat | Anti-inflammatory, antioxidant, and neuroprotective actions | (31) |
| Acorus calamus | Chronic constriction injury (CCI) in rat | Anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory actions | (32) |
| Acorus calamus | Vincristine-induced neuropathic pain in rat | Anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory actions | (33) |
| Salvia officinalis | Vincristine-induced neuropathic pain in mice | Anti-inflammatory effects | (95) |
| Koumine | CCI in rat | Elevated allopregnanolone levels through allosteric modulation of GABAA and by suppressing the release of microglia activation-induced inflammatory cytokines | (118) |
| Incarvillateine | Complete Freund’s Adjuvant (CFA), SNI and paclitaxel induced neuropathic pain in mice | Activation of the adenosine system | (114) |
| Curcumin | CCI in mice | Descending monoamine system (coupled with spinal β2-adrenoceptor and 5-HT1A receptor) | (44) |
| Curcumin | CCI in rat | Decrement the serum level of COX-2 | (45) |
| Phyllanthus amarus | CFA, PSNL in mice | Anti-inflammatory action | (82) |
| Cannabis sativa | CCI in rat | Mediated by vanilloid receptors TRPV1. | (96) |
| Momordica charantia | TST in rat | PPAR-gamma agonistic activity, anti-inflammatory, & antioxidative effects. | (72) |
| lappaconitine | CCI in rat | Regulating the purinergic signaling system at DRG level | (107) |
| Saffron’s extracts and safranal | CCI in rat | Antioxidant effects. | (48) |
| MGM-16 | PSNL in mice | Opioid agonistic effects | (70) |
| Nigella sativa and thymoquinone | STZ-induced diabetic in rat | Antioxidant actions | (76) |
| DA-9801 | STZ induced rat/mouse diabetic, db/db mouse model | Increasing the NGF level | (111) |
| Naringin | STZ induced diabetic in rat | Antioxidant and antiapoptotic activity | (120) |
| Quercetin | STZ induced diabetic in mice | Modulation of opioidergic system | (123) |
References
1. Wang LX, Wang ZJ. Animal and cellular models of chronic pain. Adv Drug Deliv Rev. 2003;55:949–965. [PubMed] [Google Scholar]
2. Razavi BM, Hosseinzadeh H. A review of the role of orexin system in pain modulation. Biomed Pharmacother. 2017;90:187–193. [PubMed] [Google Scholar]
3. Treede RD, Jensen TS, Campbell J, Cruccu G, Dostrovsky J, Griffin J, et al. Neuropathic pain redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635. [PubMed] [Google Scholar]
4. Mulla SM, Buckley DN, Moulin DE, Couban R, Izhar Z, Agarwal A, et al. Management of chronic neuropathic pain: a protocol for a multiple treatment comparison meta-analysis of randomised controlled trials. BMJ open. 2014;4(11):e006112. [PMC free article] [PubMed] [Google Scholar]
5. Gilron I, Watson CPN, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician ?Can Med Assoc J. 2006;175:265–275. [PMC free article] [PubMed] [Google Scholar]
6. Forouzanfar F, Amin B, Ghorbani A, Ghazavi H, Ghasemi F, Sadri K, et al. New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells. Eur J Pain. 2018;22:295–310. [PubMed] [Google Scholar]
7. Quintans JS, Antoniolli AR, Almeida JR, Santana-Filho VJ, Quintans-Junior LJ. Natural Products Evaluated in Neuropathic Pain Models-A Systematic Review. Basic Clin Pharmacol Toxicol. 2014;114:442–450. [PubMed] [Google Scholar]
8. Vranken JH. Current approaches to the management of peripheral neuropathic pain. J Pain Palliat Care Pharmacother. 2015;29:307–310. [PubMed] [Google Scholar]
9. Hosseinzadeh H, Moallem S, Moshiri M, Sarnavazi M, Etemad L. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung. 2012;62:324–329. [PubMed] [Google Scholar]
10. Amin B, Hajhashemi V, Hosseinzadeh H. Minocycline potentiates the anti-hyperalgesic effect of ceftriaxone in CCI-induced neuropathic pain in rats. Res Pharm Sci. 2015;10:34–42. [PMC free article] [PubMed] [Google Scholar]
11. Cohen SP, Mao J. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656. [PubMed] [Google Scholar]
12. Attal N. Neuropathic pain: mechanisms, therapeutic approach, and interpretation of clinical trials. Continuum. 2012;18:161–175. [PubMed] [Google Scholar]
13. Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000;5:578–593. [PubMed] [Google Scholar]
14. Gao Y-J, Ji R-R. Chemokines, neuronal–glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126:56–68. [PMC free article] [PubMed] [Google Scholar]
15. Fan H, Li T-F, Gong N, Wang Y-X. Shanzhiside methylester, the principle effective iridoid glycoside from the analgesic herb Lamiophlomis rotata reduces neuropathic pain by stimulating spinal microglial β-endorphin expression. Neuropharmacol. 2016;101:98–109. [PubMed] [Google Scholar]
16. Li JW-H, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325:161–165. [PubMed] [Google Scholar]
17. Boyd A, Bleakley C, Gill C, McDonough S, Hurley DA, Bell P, et al. Herbal medicinal products or preparations for neuropathic pain and fibromyalgia. Cochrane Database Syst Rev. 2013 [Google Scholar]
18. Garg G, Adams JD. Treatment of neuropathic pain with plant medicines. Chin J Integr Med. 2012;18:565–570. [PubMed] [Google Scholar]
19. Mogil JS, Davis KD, Derbyshire SW. The necessity of animal models in pain research. Pain. 2010;151:12–17. [PubMed] [Google Scholar]
20. Mabley JG, Soriano FG. Role of nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr Vasc Pharmacol. 2005;3:247–252. [PubMed] [Google Scholar]
21. Tiwari V, Kuhad A, Chopra K. Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade. Phytother Res. 2011;25:1527–1536. [PubMed] [Google Scholar]
22. Drel VR, Pacher P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov VV, et al. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol. 2007;569:48–58. [PMC free article] [PubMed] [Google Scholar]
23. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, et al. A newly identified role for superoxide in inflammatory pain. J Pharm Exp Ther. 2004;309:869–878. [PubMed] [Google Scholar]
24. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci. 2002;959:368–383. [PubMed] [Google Scholar]
25. Watcho P, Stavniichuk R, Ribnicky DM, Raskin I, Obrosova IG. High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L. Mediators Inflamm. 2010;2010:268547. [PMC free article] [PubMed] [Google Scholar]
26. Ozay R, Uzar E, Aktas A, Uyar ME, Gürer B, Evliyaoglu O, et al. The role of oxidative stress and inflammatory response in high-fat diet induced peripheral neuropathy. J Chem Neuroanat. 2014;55:51–57. [PubMed] [Google Scholar]
27. Winzell MS, Ahrén B. The high-fat diet–fed mouse a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes. 2004;53:S215–S219. [PubMed] [Google Scholar]
28. Schroder S, Beckmann K, Franconi G, Meyer-Hamme G, Friedemann T, Greten HJ, et al. Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy? Evid Based Complement Alternat Med. 2013;2013:423713. [PMC free article] [PubMed] [Google Scholar]
29. Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1–9. [PubMed] [Google Scholar]
30. Mittal N, Ginwal H, Varshney V. Pharmaceutical and biotechnological potential of Acorus calamus Linn an indigenous highly valued medicinal plant species. Pharmacogn Rev. 2009;3:83–93. [Google Scholar]
31. Muthuraman A, Singh N, Jaggi AS. Effect of hydroalcoholic extract of Acorus calamus on tibial and sural nerve transection-induced painful neuropathy in rats. J Nat Med. 2011;65:282–292. [PubMed] [Google Scholar]
32. Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med. 2011;11:24. [PMC free article] [PubMed] [Google Scholar]
33. Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats. J Nat Med. 2011;65:480–487. [PubMed] [Google Scholar]
34. Muthuraman A, Singh N. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. J Ethnopharmacol. 2012;142:723–731. [PubMed] [Google Scholar]
35. Arulmozhi S, Mazumder PM, Narayanan L, Thakurdesai P. In vitro antioxidant and free radical scavenging activity of fractions from Alstonia scholaris Linn. R. Br. Int J PharmTech Res. 2010;2:18–25. [Google Scholar]
36. Singh H, Arora R, Arora S, Singh B. Ameliorative potential of Alstonia scholaris (Linn.) R. Br. against chronic constriction injury-induced neuropathic pain in rats. BMC Complement Altern Med. 2017;17:63. [PMC free article] [PubMed] [Google Scholar]
37. Hong JH, Lee IS. Effects of Artemisia capillaris ethyl acetate fraction on oxidative stress and antioxidant enzyme in high-fat diet induced obese mice ?Chem. Biol. Interact. 2009;179:88–93. [PubMed] [Google Scholar]
38. Shahraki MR, Mirshekari H, Samadi Z. The nociceptive and anti-Inflammatory effects of Artemisia dracunculus L. aqueous extract on fructose fed male rats. J Evid Based Complementary Altern Med. 2015:895417. [PMC free article] [PubMed] [Google Scholar]
39. Thiagarajan VRK, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Antinociceptive effect of Butea monosperma on vincristine-induced neuropathic pain model in rats. Toxicol Ind Health. 2013;29:3–13. [PubMed] [Google Scholar]
40. Thiagarajan VR, Shanmugam P, Krishnan UM, Muthuraman A, Singh N. Ameliorative potential of Butea monosperma on chronic constriction injury of sciatic nerve induced neuropathic pain in rats. An Acad Bras Cienc. 2012;84:1091–1104. [PubMed] [Google Scholar]
41. Marzouk B, Marzouk Z, Haloui E, Fenina N, Bouraoui A, Aouni M. Screening of analgesic and anti-inflammatory activities of Citrullus colocynthis from southern Tunisia. J Ethnopharmacol. 2010;128:15–19. [PubMed] [Google Scholar]
42. Heydari M, Homayouni K, Hashempur MH, Shams M. Topical Citrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double-blind randomized placebo-controlled clinical trial. J Diabetes. 2016;8:246–252. [PubMed] [Google Scholar]
43. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005;1056:206–217. [PubMed] [Google Scholar]
44. Zhao X, Xu Y, Zhao Q, Chen C-R, Liu A-M, Huang Z-L. Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: descending monoamine system and opioid receptors are differentially involved. Neuropharmacol. 2012;62:843–854. [PubMed] [Google Scholar]
45. Moini Zanjani T, Ameli H, Labibi F, Sedaghat K, Sabetkasaei M. The attenuation of pain behavior and serum COX-2 concentration by curcumin in a rat model of neuropathic pain. Korean J Pain. 2014;27:246–252. [PMC free article] [PubMed] [Google Scholar]
46. Hosseinzadeh H, Modaghegh MH, Saffari Z. Crocus sativus L.(Saffron) extract and its active constituents (crocin and safranal) on ischemia-reperfusion in rat skeletal muscle. Evid Based Complement Alternat Med. 2009;6:343–350. [PMC free article] [PubMed] [Google Scholar]
47. Hosseinzadeh H, Nassiri-Asl M. Avicenna's (Ibn Sina) the canon of medicine and saffron (Crocus sativus): a review. Phytother Res. 2013;27:475–483. [PubMed] [Google Scholar]
48. Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts of saffron Crocus sativus L. and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012;83:888–895. [PubMed] [Google Scholar]
49. Alavizadeh SH, Hosseinzadeh H. Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol. 2014;64:65–80. [PubMed] [Google Scholar]
50. Sadeghnia HR, Shaterzadeh H, Forouzanfar F, Hosseinzadeh H. Neuroprotective effect of safranal, an active ingredient of Crocus sativus in a rat model of transient cerebral ischemia. Folia Neuropathol. 2017;55:206–213. [PubMed] [Google Scholar]
51. Amin B, Abnous K, Motamedshariaty V, Hosseinzadeh H. Attenuation of oxidative stress, inflammation and apoptosis by ethanolic and aqueous extracts of Crocus sativus L. stigma after chronic constriction injury of rats. An Acad Bras Cienc. 2014;86:1821–1832. [PubMed] [Google Scholar]
52. Hosseinzadeh H, Shariaty VM. Anti-nociceptive effect of safranal, a constituent of Crocus sativus (saffron), in mice. Pharmacologyonline. 2007;2:498–503. [Google Scholar]
53. Hosseinzadeh H, Younesi HM. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002;2:7. [PMC free article] [PubMed] [Google Scholar]
54. Taghavi T, Rashidy-Pour A, Vafaei AA, Sokhanvar M, Mohebbi N, Rezaei-Taviran M. Effects of saffron (Crocus Sativus L) stigma extract and its active constituent crocin on neuropathic pain responses in a rat model of chronic constriction injury. Iran J Pharm Res. 2016;15:253–261. [PMC free article] [PubMed] [Google Scholar]
55. Amin B, Hosseinzadeh H. Analgesic and anti-inflammatory effects of Crocus sativus L. (saffron) Bioactive nutraceuticals and dietary supplements in neurological and brain disease. 2014:319–324. [Google Scholar]
56. Amin B, Hosseini S, Hosseinzadeh H. Enhancement of antinociceptive effect by co-administration of Amitriptyline and Crocus Sativus in a rat model of neuropathic pain. Iran J Pharm Res. 2017;16:187–200. [PMC free article] [PubMed] [Google Scholar]
57. Karimi G, Hosseinzadeh H, Rassoulzadeh M, Razavi BM, Taghiabadi E. Antinociceptive effect of Elaeagnus angustifolia fruits on sciatic nerve ligated mice. Iran J Basic Med Sci. 2010;13:97–101. [Google Scholar]
58. Tehranizadeh ZA, Baratian A, Hosseinzadeh H. Russian olive (Elaeagnus angustifolia) as a herbal healer. Bioimpacts. 2016;6:155–167. [PMC free article] [PubMed] [Google Scholar]
59. Zargari A. Medicinal plants. Tehran: Tehran Univ Press; 1989. Persian. [Google Scholar]
60. Hosseinzadeh H, Ramezani M, Namjo N. Muscle relaxant activity of Elaeagnus angustifolia L. fruit seeds in mice. J Ethnopharmacol. 2003;84:275–278. [PubMed] [Google Scholar]
61. Hosseinzadeh H, Rahimi R. Anti-inflammatory effects of Elaeagnus angustifolia L. fruits in mice and rats. Irn J Med Sci. 1999;24:143–147. [Google Scholar]
62. Ramezani M, Hosseinzadeh H, Daneshmand N. Antinociceptive effect of Elaeagnus angustifolia fruit seeds in mice. Fitoterapia. 2001;72:255–262. [PubMed] [Google Scholar]
63. Panahi Y, Alishiri GH, Bayat N, Hosseini SM, Sahebkar A. Efficacy of Elaeagnus Angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial. Excli J. 2016;15:203–210. [PMC free article] [PubMed] [Google Scholar]
64. Lee E, Chen HY, Wu TS, Chen TY, Ayoub IA, Maynard KI. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res. 2002;68:636–645. [PubMed] [Google Scholar]
65. Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci. 2003;60:1779–1792. [PubMed] [Google Scholar]
66. Kim YS, Park HJ, Kim TK, Moon DE, Lee HJ. The effects of Ginkgo biloba extract EGb 761 on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg. 2009;108:1958–1963. [PubMed] [Google Scholar]
67. Taliyan R, Sharma P. Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats. Phytother Res. 2012;26:1823–1829. [PubMed] [Google Scholar]
68. Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem Pharm Bull. 2004;52:916–928. [PubMed] [Google Scholar]
69. Carpenter JM, Criddle CA, Craig HK, Ali Z, Zhang Z, Khan IA, et al. Comparative effects of Mitragyna speciosa extract, mitragynine, and opioid agonists on thermal nociception in rats. Fitoterapia. 2016;109:87–90. [PubMed] [Google Scholar]
70. Matsumoto K, Narita M, Muramatsu N, Nakayama T, Misawa K, Kitajima M, et al. Orally active opioid μ/δdual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice. J Pharmacol Exp Ther. 2014;348:383–392. [PMC free article] [PubMed] [Google Scholar]
71. Basch E, Gabardi S, Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm. 2003;60:356–359. [PubMed] [Google Scholar]
72. Jain V, Pareek A, Paliwal N, Ratan Y, Jaggi AS, Singh N. Antinociceptive and antiallodynic effects of Momordica charantia L. in tibial and sural nerve transection-induced neuropathic pain in rats. Nutr Neurosci. 2014;17:88–96. [PubMed] [Google Scholar]
73. Amin B, Hosseinzadeh H. Black cumin (Nigella sativa) and its active constituent, thymoquinone: an overview on the analgesic and anti-inflammatory effects. Planta Med. 2016;82:8–16. [PubMed] [Google Scholar]
74. Javidi S, Razavi BM, Hosseinzadeh H. A review of neuropharmacology effects of Nigella sativa and its main component, thymoquinone. Phytother Res. 2016;30:1219–1229. [PubMed] [Google Scholar]
75. Forouzanfar F, Fazly Bazzaz BS, Hosseinzadeh H. Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J Basic Med Sci. 2014;17:929–938. [PMC free article] [PubMed] [Google Scholar]
76. Kanter M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res. 2008;33:87–96. [PubMed] [Google Scholar]
77. Amin B, Taheri M, Hosseinzadeh H. Effects of intraperitoneal thymoquinone on chronic neuropathic pain in rats. Planta medica. 2014;80:1269–1277. [PubMed] [Google Scholar]
78. Tewari S, Salman M, Thadani S, Singh S, Ahmad A. A study of pregabalin, tramadol, their combination and Nigella sativa in neuropathic pain in rats. Int J Pharm Sci Res. 2015;6:4406. [Google Scholar]
79. Kaur G, Jaggi AS, Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj. 2010;5:3. [PMC free article] [PubMed] [Google Scholar]
80. Muthuraman A, Diwan V, Jaggi AS, Singh N, Singh D. Ameliorative effects of Ocimum sanctum in sciatic nerve transection-induced neuropathy in rats. J Ethnopharmacol. 2008;120:56–62. [PubMed] [Google Scholar]
81. Kaur G, Bali A, Singh N, Jaggi AS. Ameliorative potential of Ocimum sanctum in chronic constriction injury-induced neuropathic pain in rats. Anais da Academia Brasileira de Ciências. 2015;87:417–429. [PubMed] [Google Scholar]
82. Kassuya CA, Silvestre AA, Rehder VLG, Calixto JB. Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain. Eur J Pharmacol. 2003;478:145–153. [PubMed] [Google Scholar]
83. Nucci-Martins C, Martins DF, Nascimento LF, Venzke D, Oliveira AS, Frederico MJ, et al. Ameliorative potential of standardized fruit extract of Pterodon pubescens Benth on neuropathic pain in mice: Evidence for the mechanisms of action. J Ethnopharmacol. 2015;175:273–286. [PubMed] [Google Scholar]
84. Hoscheid J, Bersani-Amado CA, da Rocha BA, Outuki PM, da Silva MARCP, Froehlich DL, et al. Inhibitory effect of the hexane fraction of the ethanolic extract of the fruits of Pterodon pubescens Benth in acute and chronic inflammation. Evid Based Complement Alternat Med. 2013;2013:272795. [PMC free article] [PubMed] [Google Scholar]
85. Al-Sereiti M, Abu-Amer K, Sena P. Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol. 1999;37:124–130. [PubMed] [Google Scholar]
86. Yu M-H, Choi J-H, Chae I-G, Im H-G, Yang S-A, More K, et al. Suppression of LPS-induced inflammatory activities by Rosmarinus officinalis L. Food Chem. 2013;136:1047–1054. [PubMed] [Google Scholar]
87. Ghasemzadeh Rahbardar M, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L and rosmarinic acid in a rat model of neuropathic pain. Biomed Pharmacother. 2017;86:441–449. [PubMed] [Google Scholar]
88. Ghasemzadeh M, Amin B, Mehri S, Mirnajafi-Zadeh SJ, Hosseinzadeh H. Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats. J Ethnopharmacol. 2016;194:117–130. [PubMed] [Google Scholar]
89. Patel A, Patel T, Macwan C, Patel M, Chauhan K, Patel J. Evaluation of Anti-inflammatory and Analgesic activity of roots of Rubia cordifolia in rats. Journal of Pharmaceutical Sciences and Research. 2010;2:809–813. [Google Scholar]
90. Diwane C, Patil R, Vyavahare P, Bhambar R. Protective effect of Rubia cordifolia in paclitaxel-induced neuropathic pain in experimental animals. Indian J Pain. 2015;29:150–154. [Google Scholar]
91. Mansourabadi AH, Sadeghi HM, Razavi N, Rezvani E. Anti-inflammatory and analgesic properties of Salvigenin Salvia officinalis flavonoid extracted. Advanced Herbal Medicine. 2015;1:31–41. [Google Scholar]
92. Hohmann J, Zupkó I, Rédei D, Csányi M, Falkay G, Máthé I, et al. Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta Med. 1999;65:576–578. [PubMed] [Google Scholar]
93. Qnais EY, Abu-Dieyeh M, Abdulla FA, Abdalla SS. The antinociceptive and anti-inflammatory effects of Salvia officinalis leaf aqueous and butanol extracts. Pharm Biol. 2010;48:1149–1156. [PubMed] [Google Scholar]
94. Rodrigues MRA, Kanazawa LKS, Das Neves TLM, Da Silva CF, Horst H, Pizzolatti MG, et al. Antinociceptive and anti-inflammatory potential of extract and isolated compounds from the leaves of Salvia officinalis in mice. J Ethnopharmacol. 2012;139:519–526. [PubMed] [Google Scholar]
95. Abad ANA, Nouri MHK, Tavakkoli F. Effect of Salvia officinalis hydroalcoholic extract on vincristine-induced neuropathy in mice. Chin J Nat Med. 2011;9:354–358. [Google Scholar]
96. Comelli F, Giagnoni G, Bettoni I, Colleoni M, Costa B. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved. Phytother Res. 2008;22:1017–1024. [PubMed] [Google Scholar]
97. Rog DJ, Nurmikko TJ, Young CA. Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther. 2007;29:2068–2079. [PubMed] [Google Scholar]
98. Ellis RJ, Toperoff W, Vaida F, Van Den Brande G, Gonzales J, Gouaux B, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34:672–680. [PMC free article] [PubMed] [Google Scholar]
99. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39:167–179. [PubMed] [Google Scholar]
100. Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage. 2013;46:207–218. [PubMed] [Google Scholar]
101. Serpell M, Ratcliffe S, Hovorka J, Schofield M, Taylor L, Lauder H, et al. A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. Eur J Pain. 2014;18:999–1012. [PubMed] [Google Scholar]
102. Hoggart B, Ratcliffe S, Ehler E, Simpson K, Hovorka J, Lejcko J, et al. A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain. J Neurol. 2015;262:27–40. [PubMed] [Google Scholar]
103. Taki M, Omiya Y, Suzuki Y, Ikeda Y, Noguchi M, Matuba T, et al. Quality and pharmacological investigation of processed Aconiti tuber (JT-3022) Nat Med. 1998;52:343–352. [Google Scholar]
104. Murayama M, Mori T, Bando H, Amiya T. Studies on the constituents of Aconitum species IX. The pharmacological properties of pyro-type aconitine alkaloids, components of processed aconite powder 'kako-bushi-matsu': analgesic, antiinflammatory and acute toxic activities. J Ethnopharmacol. 1991;35:159–164. [PubMed] [Google Scholar]
105. Feng L, Liu W-K, Deng L, Tian J-X, Tong X-L. Clinical efficacy of aconitum-containing traditional Chinese medicine for diabetic peripheral neuropathic pain. Am J Chin Med. 2014;42:109–117. [PubMed] [Google Scholar]
106. Singhuber J, Zhu M, Prinz S, Kopp B. Aconitum in traditional Chinese medicine—a valuable drug or an unpredictable risk? J Ethnopharmacol. 2009;126:18–30. [PubMed] [Google Scholar]
107. Ou S, Zhao Y-D, Xiao Z, Wen H-Z, Cui J, Ruan H-Z. Effect of lappaconitine on neuropathic pain mediated by P2X 3 receptor in rat dorsal root ganglion. Neurochem Int. 2011;58:564–573. [PubMed] [Google Scholar]
108. Moon E, Lee SO, Kang TH, Kim HJ, Choi SZ, Son M-W, et al. Dioscorea extract (DA-9801) modulates markers of peripheral neuropathy in type 2 diabetic db/db mice. Biomol Ther. 2014;22:445–452. [PMC free article] [PubMed] [Google Scholar]
109. Maithili V, Dhanabal S, Mahendran S, Vadivelan R. Antidiabetic activity of ethanolic extract of tubers of Dioscorea alata in alloxan induced diabetic rats. Indian J Pharmacol. 2011;43:455. [PMC free article] [PubMed] [Google Scholar]
110. Gao X, Li B, Jiang H, Liu F, Xu D, Liu Z. Dioscorea opposita reverses dexamethasone induced insulin resistance. Fitoterapia. 2007;78:12–15. [PubMed] [Google Scholar]
111. Choi S-Z, Son M-W. Novel botanical drug for the treatment of diabetic neuropathy. Arch Pharm Res. 2011;34:865–867. [PubMed] [Google Scholar]
112. Kono T, Hata T, Morita S, Munemoto Y, Matsui T, Kojima H, et al. Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy. Cancer Chemother Pharmacol. 2013;72:1283–1290. [PMC free article] [PubMed] [Google Scholar]
113. Watanabe K, Shimada A, Miyaki K, Hirakata A, Matsuoka K, Omae K, et al. Long-term effects of Goshajinkigan in prevention of diabetic complications: a randomized open-labeled clinical trial. Evid Based Complement Alternat Med. 2014;2014 [PMC free article] [PubMed] [Google Scholar]
114. Wang M-L, Yu G, Yi S-P, Zhang F-Y, Wang Z-T, Huang B, et al. Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensis, and possible involvement of the adenosine system. Sci Rep. 2015;5:16107. [PMC free article] [PubMed] [Google Scholar]
115. Nakamura M, Chi Y-M, Yan W-M, Nakasugi Y, Yoshizawa T, Irino N, et al. Strong antinociceptive effect of incarvillateine, a novel monoterpene alkaloid from Incarvillea sinensis. J Nat Prod. 1999;62:1293–1294. [PubMed] [Google Scholar]
116. Chi Y-M, Nakamura M, Yoshizawa T, Zhao X-Y, Yan W-M, Hashimoto F, et al. Pharmacological study on the novel antinociceptive agent, a novel monoterpene alkaloid from Incarvillea sinensis. Biol Pharm Bull. 2005;28:1989–1991. [PubMed] [Google Scholar]
117. Jin G-L, Su Y-P, Liu M, Xu Y, Yang J, Liao K-J, et al. Medicinal plants of the genus Gelsemium (Gelsemiaceae, Gentianales)—a review of their phytochemistry, pharmacology, toxicology and traditional use. J Ethnopharmacol. 2014;152:33–52. [PubMed] [Google Scholar]
118. Qiu H-Q, Xu Y, Jin G-L, Yang J, Liu M, Li S-P, et al. Koumine enhances spinal cord 3α-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain. Mol Pain. 2015;11:1–13. [PMC free article] [PubMed] [Google Scholar]
119. Ling Q, Liu M, Wu M-X, Xu Y, Yang J, Huang H-H, et al. Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy. Biol Pharm Bull. 2014;37:858–864. [PubMed] [Google Scholar]
120. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia. 2012;83:650–659. [PubMed] [Google Scholar]
121. Hu CY, Zhao YT. Analgesic effects of naringenin in rats with spinal nerve ligation-induced neuropathic pain. Biomed Rep. 2014;2:569–573. [PMC free article] [PubMed] [Google Scholar]
122. Liu X, Liu M, Mo Y, Peng H, Gong J, Li Z, et al. Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Iran J Basic Med Sci. 2016;19:411–416. [PMC free article] [PubMed] [Google Scholar]
123. Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:1001–1005. [PubMed] [Google Scholar]
124. Qu L, Liang X, Gu B, Liu W. Quercetin alleviates high glucose-induced Schwann cell damage by autophagy ?Neural Regener Res. 2014;9:1195–203. [PMC free article] [PubMed] [Google Scholar]
125. Elbe H, Vardi N, Esrefoglu M, Ates B, Yologlu S, Taskapan C. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum Exp Toxicol. 2015;34:100–113. [PubMed] [Google Scholar]
126. Civi S, Emmez G, Dere UA, Borcek AO, Emmez H. Effects of quercetin on chronic constriction nerve injury in an experimental rat model. Acta Neurochir. 2016;158:959–965. [PubMed] [Google Scholar]
No comments:
Post a Comment